封面
市场调查报告书
商品编码
1678695

全球原代细胞培养市场:市场规模、份额、趋势分析(按产品、细胞类型、应用、最终用途和地区)、细分市场预测(2025-2030 年)

Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Primary Cells, Media), By Cell Type (Human Cells, Animal Cells) By Application (Cell & Gene Therapy Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

原代细胞培养市场的成长与趋势:

根据 Grand View Research, Inc. 的一份新报告,全球原代细胞培养市场预计到 2030 年将达到 86.7 亿美元。

预计 2025 年至 2030 年期间,市场复合年增长率为 10.55%。个人化和精准医疗的需求日益增长,推动了对更准确、更相关的体外模型的需求。原代细胞培养是研究疾病机制、药物发现和治疗方法开发的重要工具,因为与传统细胞株相比,它们更紧密地重现人类生物学和生理学。越来越多的研究人员和製药公司意识到原代细胞培养的重要性,它可以提高治疗候选药物的成功率,减少昂贵的后期失败,并最终为患者提供更有效、更有针对性的治疗方法。

此外,在旨在替换或修復受损组织和器官的再生医学领域,原代细胞培养在功能组织的发育和工程中发挥关键作用。原代细胞用于产生与天然组织的结构和功能非常相似的组织结构、类器官和生物工程植入。这些进展将对组织移植、创伤治疗和退化性疾病治疗等再生医学疗法产生重大影响。例如,2023 年 4 月,西奈山推出了新的再生医学研究所,以促进新发现并探索危及生命的疾病的新治疗方法。人们对再生医学及其彻底改变医疗保健的潜力的兴趣日益浓厚,导致对原代细胞培养的投资和研究增加,从而推动了市场的成长。

COVID-19疫情对原代细胞培养产业产生了重大影响。这场大流行扰乱了医疗保健和研究等各个行业,但也凸显了原代细胞培养在了解病毒和开发治疗方法的关键作用。原代细胞可用于研究 SARS-CoV-2 感染机制、测试抗病毒疗法和评估疫苗功效。随着世界各地的研究人员将重点放在与 COVID-19 相关的研究,疫情加速了对原代细胞培养产品和服务的需求。

此外,主要市场参与企业的多项发展和日益增长的产学合作正在推动全球市场的发展。例如,2023 年 1 月,Bio-Trac 和 ATCC 合作举办了一个培训研讨会,概述了原代细胞培养原理、类器官和球体以及其他相关的细胞培养技术。

原代细胞培养市场:分析概述

  • 根据产品,试剂和补充剂部分在 2024 年占据 37.7% 的份额。这是由于针对特定细胞类型和研究应用的高品质试剂和补充剂广泛可用。
  • 根据分离方法,酵素水解部分在 2024 年占据市场主导地位,份额为 32.15%。此方法的优点包括对培养物的损害最小、週转时间相对较短、样品产量大。
  • 根据细胞类型,动物细胞部分预计在预测期内将出现高速成长。这一领域的高成长归因于这种细胞类型的多功能性、广泛的可用性以及已建立的研究协议。
  • 由于高度发展的医疗保健基础设施和有利的政府政策,北美在全球市场中占据了强大的区域地位,到 2024 年其份额将达到 41.58%。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章 原代细胞培养市场:驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章 原代细胞培养市场:按产品分類的业务分析

  • 细分仪表板:依产品
  • 全球原代细胞培养市场:依产品变异分析
  • 全球原代细胞培养市场规模及产品趋势分析(2018-2030)
  • 原代细胞
  • 培养基
  • 试剂和补充剂

第 5 章 原代细胞培养市场:按应用的业务分析

  • 细分仪表板:依用途
  • 全球原代细胞培养市场:依应用进行变异分析
  • 全球原代细胞培养市场规模及应用趋势分析(2018-2030)
  • 疫苗生产
  • 细胞和基因治疗药物的开发
  • 模型系统
  • 病毒学
  • 产前检查
  • 其他用途

第 6 章 原代细胞培养市场:依细胞类型进行的商业分析

  • 细分仪表板:按细胞类型
  • 全球原代细胞培养市场:依细胞类型进行变异分析
  • 全球原代细胞培养市场规模及趋势分析(依细胞类型) (2018-2030)
  • 人类细胞
  • 动物细胞

第 7 章 原代细胞培养市场:依最终用途的商业分析

  • 细分仪表板:依最终用途
  • 全球原代细胞培养市场:依最终用途进行变异分析
  • 全球原代细胞培养市场规模及趋势分析(依最终用途) (2018-2030)
  • 製药和生物技术公司
  • 合约行销/合约风险评估
  • 学术研究所

第 8 章 原代细胞培养市场:区域估计和趋势分析(按产品、应用和最终用途)

  • 区域控制面板
  • 市场规模预测及趋势分析(2018-2030年)
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 参与企业
  • 战略地图
  • 企业市场分析(2024年)
  • 参与企业概况
    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell GMBH
    • ZenBio
    • AllCells
    • American Type Culture Collection
    • Axol Biosciences Ltd.
Product Code: GVR-2-68038-590-8

Primary Cell Culture Market Growth & Trends:

The global primary cell culture market size is anticipated to reach USD 8.67 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.55% from 2025 to 2030. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market's growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

Primary Cell Culture Market Report Highlights:

  • By product, the reagent and supplements segment dominated with a share of 37.7% in 2024, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
  • By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2024, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
  • By cell type, the animal cells segment is expected to grow lucratively over the forecast period. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
  • North America established a strong regional position in the global market with a 41.58% share in 2024 due to its highly developed healthcare infrastructure and favorable government policies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Cell Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
      • 3.2.1.2. Increasing in demand for stem cell therapy and regenerative medicine
      • 3.2.1.3. Rising incidence of cancer and other chronic diseases
      • 3.2.1.4. Advancement in genetic engineering protocols
      • 3.2.1.5. Rise in research funding for functional biology and research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical and regulatory concerns related with the use of primary cells
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Primary Cell Culture Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Primary Cell Culture Market Product Movement Analysis
  • 4.3. Global Primary Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Primary Cells
    • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hematopoietic Cells
      • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Skin Cells
      • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hepatocytes
      • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Gastrointestinal Cells
      • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Lung Cells
      • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Renal Cells
      • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Heart Cells
      • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Skeletal and Muscle Cells
      • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.10. Other Primary Cells
      • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Media
    • 4.5.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Serum-free Media
      • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum-containing Media
      • 4.5.3.1. Global Serum-containing Media Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Media
      • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Reagents and Supplements
    • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Attachment Solutions
      • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Buffers and Salts
      • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Sera
      • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Growth Factors and Cytokines
      • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Freezing Media
      • 4.6.6.1. Global Freezing Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.7. Others
      • 4.6.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Primary Cell Culture Market Application, Movement Analysis
  • 5.3. Global Primary Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccine Production
    • 5.4.1. Global Vaccine Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cell & Gene Therapy Development
    • 5.5.1. Global Cell & Gene Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Model System
    • 5.6.1. Global Model System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Virology
    • 5.7.1. Global Virology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Prenatal Diagnosis
    • 5.8.1. Global Prenatal Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Applications
    • 5.9.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: Cell Type Business Analysis

  • 6.1. Cell Type Segment Dashboard
  • 6.2. Global Primary Cell Culture Market Cell Type Movement Analysis
  • 6.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Human Cells
    • 6.4.1. Global Human Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Animal Cells
    • 6.5.1. Global Animal Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Primary Cell Culture Market End Use Movement Analysis
  • 7.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic Research Institutes
    • 7.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. STEMCELL Technologies
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Merck KGaA
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Lonza
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Cell Biologics, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. PromoCell GMBH
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. ZenBio
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. AllCells
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. American Type Culture Collection
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Axol Biosciences Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Primary Cell Culture market, by product, 2018 - 2030 (USD Million)
  • Table 3 Primary Cell Culture market, by end use, 2018 - 2030 (USD Million)
  • Table 4 Primary Cell Culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 5 Primary Cell Culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 Primary Cell Culture market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 10 North America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 11 North America primary culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 15 U.S. primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Canada primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 19 Canada primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 20 Mexico primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Mexico primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 23 Mexico primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Europe primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 28 Europe primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 29 UK primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 31 UK primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 32 UK primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 33 Germany primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 36 Germany primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 France primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 38 France primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 39 France primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 40 France primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Italy primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 44 Italy primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Spain primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 48 Spain primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Denmark primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 52 Denmark primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Sweden primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 56 Sweden primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Norway primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 60 Norway primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 66 Japan primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Japan primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 69 Japan primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 70 China primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 71 China primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 72 China primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 73 China primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 74 India primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 75 India primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 76 India primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 77 India primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Australia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 81 Australia primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 Thailand primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Thailand primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 85 Thailand primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Korea primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 87 South Korea primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 88 South Korea primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 89 South Korea primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Latin America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 94 Latin America primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Brazil primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 98 Brazil primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 99 Argentina primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Argentina primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 102 Argentina primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 108 South Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 110 South Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 111 South Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 116 UAE primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 118 UAE primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 119 UAE primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 120 Kuwait primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait primary cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Primary Cell Culture market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis
  • Fig. 10 Market restraint relevance analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Primary Cell Culture market: Product movement analysis
  • Fig. 14 Primary Cell Culture market, for primary cells, 2018 - 2030 (USD Million)
  • Fig. 15 Primary Cell Culture market, for reagents and supplements, 2018 - 2030 (USD Million)
  • Fig. 16 Primary Cell Culture market, for media, 2018 - 2030 (USD Million)
  • Fig. 17 Primary Cell Culture market: end use movement analysis
  • Fig. 18 Primary Cell Culture market, for pharmaceutical and biotechnology companies
  • Fig. 19 Primary Cell Culture market, for CMOs & CROs
  • Fig. 20 Primary Cell Culture market, for Academic Research Institutes
  • Fig. 21 Primary Cell Culture market: Cell Type movement analysis
  • Fig. 22 Primary Cell Culture market, for animal cells, 2018 - 2030 (USD Million)
  • Fig. 23 Primary Cell Culture market, for human cells, 2018 - 2030 (USD Million)
  • Fig. 24 Primary Cell Culture market: Application movement analysis
  • Fig. 25 Primary Cell Culture market, for cell & gene therapy development, 2018 - 2030 (USD Million)
  • Fig. 26 Primary Cell Culture market, for vaccine production, 2018 - 2030 (USD Million)
  • Fig. 27 Primary Cell Culture market, for model system, 2018 - 2030 (USD Million)
  • Fig. 28 Primary Cell Culture market, for virology, 2018 - 2030 (USD Million)
  • Fig. 29 Primary Cell Culture market, for prenatal diagnosis, 2018 - 2030 (USD Million)
  • Fig. 30 Primary Cell Culture market, for others applications, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 Regional outlook, 2024 & 2030
  • Fig. 33 Primary Cell Culture market: Region movement analysis
  • Fig. 34 North America Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 41 France Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 49 China Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 50 India Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait Primary Cell Culture market, 2018 - 2030 (USD Million)